Noticias de AUPH_US

Noticias del mercado

Últimas noticias sobre AUPH_US — 160 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AUPH_US ✕ 160 resultados
03/03/2026 AUPH_US — Stock Titan
Tang Capital boosts Aurinia (AUPH) stake to 9.2% ownership
03/03/2026 AUPH_US — Stock Titan
Tang Capital LPs tied to Aurinia (NASDAQ: AUPH) buy 900K shares
01/03/2026 AUPH_US — Yahoo Finance
Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025
28/02/2026 AUPH_US — Insider Monkey
12 Cheap Biotech Stocks to Buy Now
27/02/2026 AUPH_US — Insider Monkey
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2025 Earnings Call Transcript
27/02/2026 AUPH_US — The Globe and Mail
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
26/02/2026 AUPH_US — MarketScreener
Aurinia: Q4 Earnings Snapshot
26/02/2026 AUPH_US — Investing.com
Earnings call transcript: Aurinia Pharmaceuticals Q4 2025 earnings beat expectations
26/02/2026 AUPH_US — TipRanks
Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook
26/02/2026 AUPH_US — Yahoo Finance
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
26/02/2026 AUPH_US — Yahoo Finance
Aurinia Pharmaceuticals Q4 Earnings Call Highlights
26/02/2026 AUPH_US — BioSpace
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
26/02/2026 AUPH_US — Yahoo Finance
Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates
26/02/2026 AUPH_US — TradingView
Aurinia Pharmaceuticals Inc. SEC 10-K Report
26/02/2026 AUPH_US — MarketBeat
Aurinia Pharmaceuticals Q4 2025 Earnings Call Transcript
26/02/2026 AUPH_US — TipRanks
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
26/02/2026 AUPH_US — Business Wire
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
26/02/2026 AUPH_US — MarketScreener
Aurinia Pharmaceuticals Q4 Earnings, Revenue Rise; 2026 Revenue Outlook Set
24/02/2026 AUPH_US — TradingView
Aurinia Pharmaceuticals Inc expected to post earnings of 22 cents a share - Earnings Preview
19/02/2026 AUPH_US — Business Wire
Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026

Página 8 de 8

keyboard_arrow_up